Clinical Trial Update: Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS [Phase 4]

View source ↗

Summary

Open-label Phase 4 pilot study of memantine (Namenda) in adults with ADHD and ADHD NOS has completed; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: ADHD | Phase 4 | Status: COMPLETED | Results posted: 2012-06-07